Maternal embryonic leucine zipper kinase is a key regulator of the proliferation of malignant brain tumors, including brain tumor stem cells

Emerging evidence suggests that neural stem cells and brain tumors regulate their proliferation via similar pathways. In a previous study, we demonstrated that maternal embryonic leucine zipper kinase (Melk) is highly expressed in murine neural stem cells and regulates their proliferation. Here we describe how MELK expression is correlated with pathologic grade of brain tumors, and its expression levels are significantly correlated with shorter survival, particularly in younger glioblastoma patients. In normal human astrocytes, MELK is only faintly expressed, and MELK knockdown does not significantly influence their growth, whereas Ras and Akt overexpressing astrocytes have up‐regulated MELK expression, and the effect of MELK knockdown is more prominent in these transformed astrocytes. In primary cultures from human glioblastoma and medulloblastoma, MELK knockdown by siRNA results in inhibition of the proliferation and survival of these tumors. Furthermore, we show that MELK siRNA dramatically inhibits proliferation and, to some extent, survival of stem cells isolated from glioblastoma in vitro. These results demonstrate a critical role for MELK in the proliferation of brain tumors, including their stem cells, and suggest that MELK may be a compelling molecular target for treatment of high‐grade brain tumors. © 2007 Wiley‐Liss, Inc.

[1]  T. Shimazaki,et al.  [Mammalian neural stem cells]. , 2008, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme.

[2]  Ivan Radovanovic,et al.  HEDGEHOG-GLI1 Signaling Regulates Human Glioma Growth, Cancer Stem Cell Self-Renewal, and Tumorigenicity , 2007, Current Biology.

[3]  Mark W. Dewhirst,et al.  Glioma stem cells promote radioresistance by preferential activation of the DNA damage response , 2006, Nature.

[4]  K. Black,et al.  Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma , 2006, Molecular Cancer.

[5]  Yuri Kotliarov,et al.  Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. , 2006, Cancer cell.

[6]  T. Curran,et al.  Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  Thomas D. Wu,et al.  Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. , 2006, Cancer cell.

[8]  P. Wen,et al.  Targeted molecular therapy of malignant gliomas , 2005, Current oncology reports.

[9]  Koji Yoshimoto,et al.  Distinct transcription profiles of primary and secondary glioblastoma subgroups. , 2006, Cancer research.

[10]  M. Bollen,et al.  Substrate Specificity and Activity Regulation of Protein Kinase MELK* , 2005, Journal of Biological Chemistry.

[11]  David P. Davis,et al.  Maternal embryonic leucine zipper kinase/murine protein serine-threonine kinase 38 is a promising therapeutic target for multiple cancers. , 2005, Cancer research.

[12]  Amar Gajjar,et al.  Radial glia cells are candidate stem cells of ependymoma. , 2005, Cancer cell.

[13]  Hong Wu,et al.  Maternal embryonic leucine zipper kinase (MELK) regulates multipotent neural progenitor proliferation , 2005, The Journal of cell biology.

[14]  J. Nevins,et al.  E2Fs link the control of G1/S and G2/M transcription , 2004, The EMBO journal.

[15]  R. Henkelman,et al.  Identification of human brain tumour initiating cells , 2004, Nature.

[16]  C. Colwell,et al.  Selective deficits in the circadian light response in mice lacking PACAP. , 2004, American journal of physiology. Regulatory, integrative and comparative physiology.

[17]  Ugo Orfanelli,et al.  Isolation and Characterization of Tumorigenic, Stem-like Neural Precursors from Human Glioblastoma , 2004, Cancer Research.

[18]  S. Horvath,et al.  Gene Expression Profiling of Gliomas Strongly Predicts Survival , 2004, Cancer Research.

[19]  M. Bollen,et al.  Inhibition of Spliceosome Assembly by the Cell Cycle-regulated Protein Kinase MELK and Involvement of Splicing Factor NIPP1* , 2004, Journal of Biological Chemistry.

[20]  Jérôme Boudeau,et al.  LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR‐1 , 2004, The EMBO journal.

[21]  H. Newton.  Molecular neuro-oncology and development of targeted therapeutic strategies for brain tumors. Part 2: PI3K/Akt/PTEN, mTOR, SHH/PTCH and angiogenesis , 2004, Expert review of anticancer therapy.

[22]  NewtonHB.  Molecular neuro-oncology and development of targeted therapeutic strategies for brain tumors , 2004 .

[23]  D. Geschwind,et al.  Neural progenitor genes. Germinal zone expression and analysis of genetic overlap in stem cell populations. , 2003, Developmental biology.

[24]  Daniel H. Geschwind,et al.  Cancerous stem cells can arise from pediatric brain tumors , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[25]  Mina Kim,et al.  Distinct Populations of Forebrain Neural Stem and Progenitor Cells Can Be Isolated Using Side-Population Analysis , 2003, The Journal of Neuroscience.

[26]  H. Esumi,et al.  ARK5 suppresses the cell death induced by nutrient starvation and death receptors via inhibition of caspase 8 activation, but not by chemotherapeutic agents or UV irradiation , 2003, Oncogene.

[27]  Cynthia Hawkins,et al.  Identification of a cancer stem cell in human brain tumors. , 2003, Cancer research.

[28]  H. Esumi,et al.  Identification of a Novel Protein Kinase Mediating Akt Survival Signaling to the ATM Protein* , 2003, The Journal of Biological Chemistry.

[29]  J. Waschek,et al.  Pituitary Adenylate Cyclase-Activating Polypeptide and Sonic Hedgehog Interact to Control Cerebellar Granule Precursor Cell Proliferation , 2002, The Journal of Neuroscience.

[30]  V. Baldin,et al.  Human pEg3 kinase associates with and phosphorylates CDC25B phosphatase: a potential role for pEg3 in cell cycle regulation , 2002, Oncogene.

[31]  M. Miyazaki,et al.  Critical roles of AMP-activated protein kinase in constitutive tolerance of cancer cells to nutrient deprivation and tumor formation , 2002, Oncogene.

[32]  T. Poggio,et al.  Prediction of central nervous system embryonal tumour outcome based on gene expression , 2002, Nature.

[33]  A. Trumpp,et al.  Negative Regulation of Neural Stem/Progenitor Cell Proliferation by the Pten Tumor Suppressor Gene in Vivo , 2001, Science.

[34]  D. Geschwind,et al.  Molecular markers in CNS stem cell research: hitting a moving target , 2001, Nature Reviews Neuroscience.

[35]  K. Aldape,et al.  Formation of intracranial tumors by genetically modified human astrocytes defines four pathways critical in the development of human anaplastic astrocytoma. , 2001, Cancer research.

[36]  Irving L. Weissman,et al.  A Genetic Analysis of Neural Progenitor Differentiation , 2001, Neuron.

[37]  C. Li,et al.  Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[38]  Y. Luo,et al.  All trans-retinoic acid suppresses in vitro growth and down-regulates LIF gene expression as well as telomerase activity of human medulloblastoma cells. , 2000, Anticancer research.

[39]  F. Gage,et al.  Mammalian neural stem cells. , 2000, Science.

[40]  D. Trono,et al.  Self-Inactivating Lentivirus Vector for Safe and Efficient In Vivo Gene Delivery , 1998, Journal of Virology.

[41]  R. Derynck,et al.  Abnormal astrocyte development and neuronal death in mice lacking the epidermal growth factor receptor , 1998, Journal of neuroscience research.

[42]  M. Scott,et al.  Altered neural cell fates and medulloblastoma in mouse patched mutants. , 1997, Science.

[43]  B. Kemp,et al.  Isoform-specific Purification and Substrate Specificity of the 5′-AMP-activated Protein Kinase* , 1996, The Journal of Biological Chemistry.

[44]  G. Neubauer,et al.  A strategy for identifying gel-separated proteins in sequence databases by MS alone. , 1996, Biochemical Society transactions.

[45]  F. Gage,et al.  In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector , 1996, Science.

[46]  B. Kemp,et al.  Mammalian AMP-activated Protein Kinase Subfamily (*) , 1996, The Journal of Biological Chemistry.

[47]  F. Gage,et al.  FGF-2-Responsive Neuronal Progenitors Reside in Proliferative and Quiescent Regions of the Adult Rodent Brain , 1995, Molecular and Cellular Neuroscience.

[48]  H. Chugani,et al.  Cerebral hemidecortication alters expression of transforming growth factor alpha mRNA in the neostriatum of developing rats. , 1994, Brain research. Molecular brain research.

[49]  S. Weiss,et al.  Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. , 1992, Science.

[50]  D. Cox,et al.  Analysis of Survival Data. , 1985 .

[51]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .